Immune checkpoint inhibitor is named as a drug or biological intervention in 8 clinical trials in our China and USA trial registers, 6 of which are recruiting. Lead sponsors include ImmuneSensor Therapeutics Inc. (1), Domain Therapeutics Australia Pty Ltd (1) and Tongji Hospital (1). Registered phases: Phase 2, Phase 1, Phase 1/2, Observational and Phase 3. Conditions studied include Solid Tumor, Adult; Advanced Solid Tumors; Hepatocellular Carcinoma.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Solid Tumor, Adult | 1 |
| Advanced Solid Tumors | 1 |
| Hepatocellular Carcinoma | 1 |
| Gastric Cancer | 1 |
| Second-line Treatment | 1 |
| Head and Neck Squamous Cell Carcinoma | 1 |
| Colorectal Cancer | 1 |
| Nasopharyngeal Carcinoma | 1 |
| Immune Checkpoint Inhibitor | 1 |
| Radiotherapy | 1 |
| Chemotherapy | 1 |
| Locally Advanced Colorectal Carcinoma | 1 |
| Lead sponsor | Trials |
|---|---|
| ImmuneSensor Therapeutics Inc. | 1 |
| Domain Therapeutics Australia Pty Ltd | 1 |
| Tongji Hospital | 1 |
| Fudan University | 1 |
| West China Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| Sun Yat-sen University | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Register | Immune checkpoint inhibitor trials |
|---|---|
| Clinical trials in China | 6 |
| Clinical trials in USA | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Immune checkpoint inhibitor works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Immune checkpoint inhibitor (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.